CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $56K of Crinetics Pharmaceuticals, Inc.
Sold$56,268
$18.00Price
3,126Shares
−4%Stake
What CRNX did after the filing
- The stock from Thu, Jan 19 close, $19.01
- +0.8%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Mar 3 close.
Traded Tue, Jan 17. Filed Thu, Jan 19, 11:28 AM ET, during the session. Returns use the Jan 19 close and the Mar 3 close. Not investment advice.